Metabolic Features of Melanoma: A Gold Mine of New Therapeutic Targets?

ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)

Volume 17, 9 Issues, 2017

Download PDF Flyer

Current Cancer Drug Targets

This journal supports open access

Aims & ScopeAbstracted/Indexed in

Ranking and Category:
  • 68th of 213 in Oncology

Submit Abstracts Online Submit Manuscripts Online

Ruiwen Zhang
Texas Tech University Health Sciences Center
1300 Coulter Drive
Amarillo, TX 79106

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 3.707
5 - Year: 3.446

Metabolic Features of Melanoma: A Gold Mine of New Therapeutic Targets?

Current Cancer Drug Targets, 14(4): 357-370.

Author(s): Philippe Marchetti, Pierre Guerreschi, Jerome Kluza and Laurent Mortier.

Affiliation: INSERM U 837 Faculte de Medecine, 1, place Verdun F- 59045 Lille Cedex, France.


In recent years, our knowledge regarding the metabolism of melanoma has greatly advanced and consequently new therapeutic strategies are being developed. This review is focused on metabolic pathways contributing to melanoma proliferation, the influence of BRAF inhibitors on those metabolic pathways and finally a presentation of potential therapeutic strategies aimed at blocking metabolic signaling pathways and therefore melanoma development.


Glycolysis, mitochondria, oxidative stress, warburg.

Purchase Online Order Reprints Order Eprints Rights and Permissions

Article Details

Volume: 14
Issue Number: 4
First Page: 357
Last Page: 370
Page Count: 14
DOI: 10.2174/1568009614666140407113124
Price: $58
Orphan Drugs and Rare Diseases Europe 2017

Related Journals

Webmaster Contact: Copyright © 2016 Bentham Science